Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Robins' Dalkon Shield notification program

Executive Summary

Firm alerting users of the intrauterine device that April 30 is deadline for filing claims of injury linked to use of the device. Program will run Jan. 6-25 and will include print ads in 225 newspapers and several national weekly magazines and 30-second television spots broadcast by network and cable stations. Projecting costs of $5 mil., Robins will also issue news releases, public service announcements, and letters to foreign health officials in approximately 80 countries.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS009529

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel